In addition, LINC01133 was found to aggravate the progression of hepatocellular carcinoma and non-small cell lung cancer by activating the PI3K/ATK pathway or by repressing KLF2/E-cadherin 25, 26. The gene discussed is CDH1; the disease is non-small cell lung carcinoma.